No abstract available
MeSH terms
-
Anemia / etiology
-
Anemia / metabolism
-
Anti-Bacterial Agents / therapeutic use
-
Anti-Ulcer Agents / therapeutic use
-
Comorbidity
-
Disease Susceptibility
-
Drug Therapy, Combination
-
Duodenal Diseases / complications*
-
Duodenal Diseases / epidemiology
-
Duodenal Diseases / microbiology
-
Duodenal Ulcer / complications
-
Duodenal Ulcer / epidemiology
-
Duodenal Ulcer / microbiology
-
Enzyme Inhibitors / therapeutic use
-
Gastrins / metabolism
-
Helicobacter Infections / complications*
-
Helicobacter Infections / diagnosis
-
Helicobacter Infections / drug therapy
-
Helicobacter Infections / epidemiology
-
Helicobacter Infections / microbiology
-
Helicobacter Infections / physiopathology
-
Helicobacter pylori*
-
Humans
-
Kidney Failure, Chronic / complications*
-
Kidney Failure, Chronic / epidemiology
-
Kidney Failure, Chronic / therapy
-
Malabsorption Syndromes / etiology
-
Prevalence
-
Proton Pump Inhibitors
-
Renal Dialysis* / adverse effects
-
Stomach Diseases / complications*
-
Stomach Diseases / epidemiology
-
Stomach Diseases / microbiology
-
Stomach Ulcer / complications
-
Stomach Ulcer / epidemiology
-
Stomach Ulcer / microbiology
-
Urea / metabolism
Substances
-
Anti-Bacterial Agents
-
Anti-Ulcer Agents
-
Enzyme Inhibitors
-
Gastrins
-
Proton Pump Inhibitors
-
Urea